PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 155 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,061,000 | -25.4% | 279,220 | -0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,422,000 | +7.9% | 279,303 | +7.1% | 0.00% | 0.0% |
| Q3 2019 | $1,318,000 | -17.0% | 260,795 | +1.3% | 0.00% | -33.3% |
| Q2 2019 | $1,588,000 | +42.2% | 257,328 | +6.9% | 0.00% | +50.0% |
| Q1 2019 | $1,117,000 | +9.6% | 240,761 | -0.8% | 0.00% | 0.0% |
| Q4 2018 | $1,019,000 | -17.6% | 242,734 | +23.1% | 0.00% | 0.0% |
| Q3 2018 | $1,237,000 | -14.4% | 197,251 | +9.8% | 0.00% | -33.3% |
| Q2 2018 | $1,445,000 | +17.7% | 179,714 | +9.2% | 0.00% | 0.0% |
| Q1 2018 | $1,228,000 | +29.4% | 164,634 | +3.2% | 0.00% | +50.0% |
| Q4 2017 | $949,000 | -7.1% | 159,560 | +15.0% | 0.00% | 0.0% |
| Q3 2017 | $1,021,000 | +10.7% | 138,707 | +2.2% | 0.00% | 0.0% |
| Q2 2017 | $922,000 | -28.1% | 135,737 | -0.0% | 0.00% | -33.3% |
| Q1 2017 | $1,282,000 | +90.8% | 135,769 | +74.7% | 0.00% | +50.0% |
| Q4 2016 | $672,000 | +44.5% | 77,727 | +5.7% | 0.00% | +100.0% |
| Q3 2016 | $465,000 | +36.0% | 73,523 | -9.2% | 0.00% | 0.0% |
| Q2 2016 | $342,000 | +12.5% | 80,988 | +16.1% | 0.00% | 0.0% |
| Q1 2016 | $304,000 | -28.3% | 69,765 | +0.9% | 0.00% | 0.0% |
| Q4 2015 | $424,000 | +14.6% | 69,130 | +6.8% | 0.00% | 0.0% |
| Q3 2015 | $370,000 | -20.6% | 64,725 | +3.7% | 0.00% | 0.0% |
| Q2 2015 | $466,000 | -12.7% | 62,403 | -30.1% | 0.00% | -50.0% |
| Q1 2015 | $534,000 | -18.3% | 89,293 | +3.2% | 0.00% | 0.0% |
| Q4 2014 | $654,000 | +58.0% | 86,493 | +8.4% | 0.00% | +100.0% |
| Q3 2014 | $414,000 | +20.3% | 79,793 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $344,000 | +62.3% | 79,793 | +53.8% | 0.00% | 0.0% |
| Q1 2014 | $212,000 | -26.1% | 51,879 | -3.6% | 0.00% | 0.0% |
| Q4 2013 | $287,000 | +5.9% | 53,789 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $271,000 | +12.9% | 53,789 | +0.1% | 0.00% | 0.0% |
| Q2 2013 | $240,000 | – | 53,717 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|